| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Rein Therapeutics, Inc. (RNTX) has 6 insiders with recent SEC Form 4 filings, including 13 buys and 0 sells. RNTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 926.4K | $858.0K | - | |
| Dir | 17.5K | $16.2K | - | |
| Dir | 17.5K | $16.2K | - | |
| Dir | 17.5K | $16.2K | - | |
| Dir | 17.5K | $16.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 15, 2020 | Ambros Reinhard J. | Director | Buy | 5,800 | $1.22 | $7,076.00 | New | |
| Jun 8, 2020 | Satter Muneer A58 | Director, 10% Owner, See Remarks | Buy | 3,700,000 | $1.10 | $4,070,000.00 | +94.6% | |
| Jun 8, 2020 | Von Rickenbach Josef H | Director | Buy | 227,272 | $1.10 | $249,999.20 | +104.2% | |
| Nov 15, 2019 | Bailey Jeffrey Allen | Director | Buy | 55,000 | $0.51 | $28,050.00 | +98.8% | |
| Nov 12, 2019 | Bailey Jeffrey Allen | Director | Buy | 19,894 | $0.53 | $10,543.82 | New | |
| Sep 13, 2019 | Von Rickenbach Josef H | Director | Buy | 113,145 | $0.98 | $110,504.88 | +37.9% | |
| Sep 4, 2019 | Von Rickenbach Josef H | Director | Buy | 23,225 | $0.71 | $16,582.65 | +28.4% | |
| Sep 3, 2019 | Von Rickenbach Josef H | Director | Buy | 28,466 | $0.72 | $20,395.55 | +23.4% | |
| Aug 29, 2019 | Von Rickenbach Josef H | Director | Buy | 3,600 | $0.77 | $2,770.92 | +7.2% | |
| Aug 16, 2019 | Vukovic Vojo | SVP, Chief Medical Officer | Buy | 75,000 | $0.59 | $44,452.50 | New |